Search results
Results from the WOW.Com Content Network
Investors betting on marijuana stocks got some disappointing news out of Canada last week. Statistics Canada reported that Canadian marijuana retail sales declined by 7% in February compared to ...
If medical marijuana can gain approval in that part of the U.S., it can easily become legal in all 50 states soon. Also, federal restrictions have hampered the growth of U.S.-based firms in this ...
Cannabis stocks are having a blistering start to 2019. The sector appeared to have peaked in the fall of 2018. As many had warned, marijuana stocks turned sharply lower following Canada's ...
Zenabis received its sales license for dried marijuana from Health Canada in 2018, [1] and received its license to sell cannabis oil in March 2019. [ 3 ] [ 4 ] In January 2019, Zenabis’s parent company Sun Pharm completed a reverse take-over of Bevo Agro Inc., leading to the two firms operating under the banner of Zenabis Global Inc. [ 5 ...
But there are even more important things you'll want to know about Cronos Group's Q2 results.
VIVO received two of the first 15 licences by Health Canada in 2014. [2] It became a publicly traded company in April 2017 on the TSX Venture Exchange.In August 2017, the company received a $15 million investment by Cannabis Wheaton to fund the second production facility at its 65-acre property in Napanee. [3]
CanniMed Therapeutics Inc. is a Canadian public licensed producer of medical cannabis.It is primarily focused on cannabis oil.The company's predecessor, Prairie Plant Systems, was established in 1988 and is located in Saskatoon, Saskatchewan.
Extraction cannabis company MediPharm Labs (MEDIF) has been accelerating its upward growth trajectory at the right time, as Canada is poised to give the go ahead for derivatives to be sold in the ...